ChrisMStorgardMD

Rheumatology • San Diego, CA

Physician

Join to view full profile

Dr. Storgard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Storgard's full profile

Already have an account?

Office
14865 Whispering Ridge Rd
San Diego, CA 92131
Phone+1 858-610-7159

Education & Training

Scripps Clinic/Scripps Green HospitalFellowship, Rheumatology, 1995 - 1997
University of Arizona College of Medicine-Tucson (South Campus)Residency, Internal Medicine, 1992 - 1993
University Saskatchewan Royal HospitalClass of 1991

Certifications & Licensure

CA State Medical License 1995 - 2024
MN State Medical License 2001 - 2004

Clinical Trials

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors Start of enrollment: 2018 Jan 18
Completed
Phase 1

Publications & Presentations

PubMed

115 citations
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the...
Thomas Bardin, Robert T. Keenan, Puja P. Khanna, J. Kopicko, Maple Fung
Annals of the Rheumatic Diseases. 2017-05-01
78 citations
Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study.
Anne-Kathrin Tausche, Rieke Alten, Nicola Dalbeth, J. Kopicko, Maple Fung
Rheumatology. 2017-12-01
104 citations
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial
Nicola Dalbeth, Graeme Jones, Robert Terkeltaub, Dinesh Khanna, J. Kopicko
Arthritis & Rheumatology. 2017-09-01

Press Mentions

Could This Be a Turning Point for Fate Therapeutics?June 20th, 2016
Astrazeneca Presents Positive Update on Lesinurad Renal Data in Gout PatientsNovember 12th, 2015

Grant Support

Angiogenesis &Alpha V Integrins In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001–2003
Angiogenesis &Alpha V Integrins In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2000
Angiogenesis And Alpha V Integrins In Rheumatoid ArthritNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999